Latest News of ADPT
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...
By Yahoo! Finance |
2 weeks ago
The new gapfill price of $2,007 per test will positively impact long-term margins, with an expected increase in average selling price to $1,300 in 2025....
Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of three-year loss
By Yahoo! Finance |
3 months ago
Adaptive Biotechnologies' stock price has shown a 72% increase in the last quarter, but a significant 88% drop over the past three years. Shareholders hope for sustained growth despite recent improvem...